Studying a new sepsis score in Turkish ICUs
Part of Infections clinical trials.
This trial tests a new scoring system called SOFA-2 to better predict death and identify sepsis in adults staying in intensive care units (ICUs) in Turkey.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are currently in an intensive care unit (ICU).
- You will stay in the ICU for at least 24 hours (for one part of the study).
- You are not in a children's ICU, heart surgery ICU, or coronary care unit.
- You are not in the ICU only for organ donation.
- Your medical records have the information needed to calculate the score.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies people with and without sepsis in the ICU to understand why some get very sick from infections. It aims to find better ways to predict who will have complications and guide treatment.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
This study tests whether adding information about stomach and intestine function to an existing ICU scoring system helps doctors better predict which patients are at highest risk. Researchers will collect your medical data during your first 24 hours in the ICU to see if this new approach works.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study looks at how the immune system changes in people with sepsis (a severe response to infection that can cause organ failure). It aims to understand immune dysfunction to help improve treatments.
This study observes how doctors treat septic shock in intensive care units. It aims to understand current practices and improve care for patients with severe infections and low blood pressure.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.